Eagle Pharmaceuticals logo
Eagle Pharmaceuticals EGRX
$ 2.14 -39.89%

Quarterly report 2023-Q2
added 08-08-2023

report update icon

Eagle Pharmaceuticals Total Current Liabilities 2011-2024 | EGRX

Annual Total Current Liabilities Eagle Pharmaceuticals

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
111 M 74.4 M 38.1 M 38.8 M 39.7 M 47.3 M 41 M 34.3 M 22.2 M - - -

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
111 M 22.2 M 49.6 M